TITLE

Commentary on: First American experience with the Terumo DuraHeart ventricular assist system

AUTHOR(S)
Griffith, K
PUB. DATE
March 2009
SOURCE
Perfusion;Mar2009, Vol. 24 Issue 2, p91
SOURCE TYPE
Academic Journal
DOC. TYPE
Proceeding
ABSTRACT
Information about issues discussed at the 30th Annual Seminar of the American Academy of Cardiovascular Perfusion held in Dallas, Texas from February 5-8, 2009 is presented. Topics include anticoagulation and the use of Terumo DuraHeart ventricular assist system among professionals in the field. The event featured several speakers including Justin Resley, Kevin Griffith and James Beck.
ACCESSION #
43590257

 

Related Articles

  • The relationship between heparin level and activated clotting time in the adult cardiac surgery population. FitzGerald, D. J.; Patel, A.; Body, S. C.; Garvin, S. // Perfusion;Mar2009, Vol. 24 Issue 2, p93 

    The purpose of this descriptive study was to examine the relationship between heparin levels (HL) determined by heparin protamine titration (HPT) and activated clotting time (ACT) for cardiopulmonary bypass (CPB) in an adult cardiac surgery population. We examined institutional databases for all...

  • Commentary on: The relationship between heparin level and activated clotting time in the adult cardiac surgery population. FitzGerald, D. // Perfusion;Mar2009, Vol. 24 Issue 2, p97 

    Information about the issues discussed at the 30th Annual Seminar of the American Academy of Cardiovascular Perfusion held in Dallas, Texas from February 5-8, 2009 is presented. Topics include the relationship of heparin level and activated clotting time in the adult cardiac surgery populace....

  • Keeping anticoagulants under control. Hand, John // RN;Apr79, Vol. 42 Issue 4, p25 

    Focuses on the importance of keeping anticoagulants under control to prevent blood clot formation. Preventive measures for blood clot formation; Limitations in choosing anticoagulant drugs; Information on how anticoagulants prevent blood clots; Guidelines for average anticoagulant dosage.

  • Rivaroxaban reduces risk of death after MI.  // Medical Economics;1/10/2012, Vol. 89 Issue 1, p71 

    The article reports that oral anticoagulant rivaroxaban reduced the risk of death in a large randomized study.

  • Anticoagulant update - correction.  // British Dental Journal;9/28/2013, Vol. 215 Issue 6, p266 

    A correction to the letter to the editor on anticoagulant update is presented.

  • Anticoagulant therapy.  // Nursing Standard;1/20/2010, Vol. 24 Issue 20, p56 

    A quiz concerning anticoagulant therapy is presented.

  • Extending prophylaxis with oral anticoagulant.  // British Journal of Hospital Medicine (17508460);Aug2008, Vol. 69 Issue 8, p439 

    The article reports on the RECORD2 (REgulation of Coagulation in major Orthopaedic surgery reducing the Risk of DVT and PE) study that sustains the benefit of extended thromboprophylaxis with rivaroxaban. The study subjects 2500 patients undergoing total hip replacement surgery to compare the...

  • Perspectives on Factor Xa Inhibition. Rai, R.; Sprengeler, P.A.; Elrod, K.C.; Young, W.B. // Current Medicinal Chemistry;Feb2001, Vol. 8 Issue 2, p101 

    Blood coagulation involves a complex cascade of enzymatic reactions, ultimately generating fibrin, the basis of all blood clots. This cascade is comprised of two arms, the intrinsic and extrinsic pathways which converge at factor Xa to form the common pathway. Factor Xa activates prothrombin to...

  • Coagulation disorders and anti-coagulants. Bansal, Pranav; Jain, gaurav // Anaesthesia, Pain & Intensive Care;Oct-Dec2011, Vol. 15 Issue 3, p198 

    A quiz concerning blood coagulation disorders and anti-coagulants in the management of patients with neuraxial block is presented.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics